Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications.

Autor: Gugelmo G; Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, Padova, 35128, Italy., Maines E; Division of Pediatrics, Santa Chiara General Hospital, APSS, Trento, 38122, Italy., Boscari F; Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, Padova, 35128, Italy., Lenzini L; Department of Medicine, Padova University Hospital, Padova, 35128, Italy., Fadini GP; Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, Padova, 35128, Italy., Burlina A; Division of Inherited Metabolic Diseases, Reference Centre Expanded Newborn Screening, Department of Women's and Children's Health, Padova University Hospital, Padova, 35128, Italy., Avogaro A; Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, Padova, 35128, Italy., Vitturi N; Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, Padova, 35128, Italy. nicola.vitturi@aopd.veneto.it.
Jazyk: angličtina
Zdroj: Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2024 Oct; Vol. 25 (5), pp. 897-910. Date of Electronic Publication: 2024 Oct 01.
DOI: 10.1007/s11154-024-09903-y
Abstrakt: Managing Inherited Metabolic Disorders (IMDs) at risk for hypoglycemia, such as Glycogen Storage Diseases (GSDs), Hereditary Fructose Metabolism Disorders (HFMDs) and Congenital Hyperinsulinism (CH), poses challenges in dietary treatments and blood glucose monitoring. The effectiveness of Continuous Glucose Monitoring (CGM) remains a subject of ongoing debate, with IMD guidelines maintaining caution. Therefore, a systematic evaluation is needed to understand the potential benefits of CGM during dietary interventions. A systematic literature review was conducted in PubMed according to the PICOS model and PRISMA recommendations on studies published from January 01, 2003, up to October 15, 2023 (PROSPERO CRD42024497744). The risk of bias was assessed using NIH Quality Assessment Tools. Twenty-four studies in GSDs (n = 13), CH (n = 10), and HFMDs (n = 1) were analyzed. In GSDs, Real-time CGM (Rt-CGM) was associated with metabolic benefits during nutritional interventions, proving to be an accurate system for hypoglycemia detection although with some concerns about reliability. Rt-CGM in CH, primarily involving children, also showed potential benefits for glycemic control and metabolic stability with acceptable accuracy, although its use during dietary changes was limited. Few experiences on Flash Glucose Monitoring (FGM) were reported, with some concerns about reliability. Overall, the studies analyzed presented different designs, and their quality was predominantly fair or poor. Heterogeneity and limited consensus on reliability and glycemic targets underscore the need for prospective studies and future recommendations for the use of CGM in optimizing nutritional status and providing personalized dietary education in individuals with IMDs prone to hypoglycemia.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: